TY  - GEN
AU  - Tsuzuki,Toyonori
AU  - Sassa,Naoto
AU  - Shimoyama,Yoshie
AU  - Morikawa,Takamitsu
AU  - Shiroki,Ryoichi
AU  - Kuroda,Makoto
AU  - Fukatsu,Akitoshi
AU  - Kuwahara,Kyoko
AU  - Yoshino,Yasushi
AU  - Hattori,Ryohei
AU  - Gotoh,Momokazu
TI  - Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism
SN  - 1365-2559
PY  - 2014///1020
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Carcinoma, Renal Cell
KW  - blood supply
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neovascularization, Pathologic
KW  - drug therapy
KW  - Nephrectomy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyrroles
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Retrospective Studies
KW  - Sorafenib
KW  - Sunitinib
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/his.12277
ER  -